NCT00340158
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +13 more
- Locations
-
- National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Inflammatory Breast Neoplasms
Explore clinical trials studying Inflammatory Breast Neoplasms. Study availability and eligibility vary by location and protocol.
74 public trials
6 recruiting studies
Inflammatory Breast Neoplasms trial results
NCT02411656
- Conditions
- Breast Diseases, Breast Neoplasms, Edema, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
NCT02623972
- Conditions
- Breast Diseases, Breast Neoplasms, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, +6 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
NCT03598257
- Conditions
- Breast Diseases, Breast Inflammatory Carcinoma, Breast Neoplasms, +5 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Anchorage Oncology Centre Anchorage, Alaska, United States
- Katmai Oncology Group Anchorage, Alaska, United States
Active, Not Recruiting
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
NCT03012100
- Conditions
- Bilateral Breast Carcinoma, Breast Diseases, Breast Inflammatory Carcinoma, +18 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
Active, Not Recruiting
Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
NCT02971748
- Conditions
- Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Diseases, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer
NCT03202316
- Conditions
- Breast Diseases, Breast Neoplasms, Inflammatory Breast Neoplasms, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.
NCT04200768
- Conditions
- Body Weight, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- UZ Leuven Leuven, Belgium
Active, Not Recruiting
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
NCT02876107
- Conditions
- Breast Carcinoma, Breast Diseases, Breast Lump, +19 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
NCT01525966
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +15 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope- South Pasadena Cancer Center South Pasadena, California, United States